RCAR News and Press, Renovacare Inc From 09/22/23

Regenicin Inc (RGIN) is expected to report for quarter end 2023-06-30 Grasim Industries Ltd. ADR (GRSXY) is expected to report for quarter end 2023-06-30 Mitsubishi Heavy Industries Ltd. (MHVYF) is expected to report for Q1 2024 Japan Tobacco Inc. ADR (JAPAY) is expected to report $0....

World Copper (WCUFF) is expected to report $-0.01 for Q2 2023 GlassBridge Enterprises Inc (GLAE) is expected to report for quarter end 2023-06-30 Paladin Energy Ltd (PALAF) is expected to report for Q4 2023 Andritz AG ADR (ADRZY) is expected to report for Q2 2023 Cincinnati Bancor...

Anebulo Pharmaceuticals Inc. (ANEB) is expected to report for Q4 2023 Minera IRL Ltd ADR (MRLLY) is expected to report for Q3 2023 OpenLocker Holdings Inc (OLKR) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-0.43 for Q2 2024 Sompo Holdings I...

Greenrose Holding Company Inc The Com (GNRS) is expected to report for quarter end 2023-06-30 Bridgford Foods Corporation (BRID) is expected to report for Q1 2024 Compagnie financiere Richemont SA ADR (CFRUY) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is e...

RenovaCare Inc (RCAR) is expected to report for quarter end 2023-06-30

SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced the termination of...

RenovaCare (OTCPK:RCAR) announced reductions in its management team for streamlining administrative expenses. Dr. Kaiyo Nedd resigned as Interim President, CEO and Director, and Mr. Justin Frere as CFO and Secretary. Dr. Nedd will continue to provide ongoing supp...

SCOTTSDALE, Ariz., March 24, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced reductions in it...

SCOTTSDALE, Ariz., March 09, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced that following t...

RM LAW Announces Investigation of RenovaCare, Inc. PR Newswire BERWYN, Pa. , Feb. 3, 2022 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of RenovaCare, Inc. (OTC: RCAR) investors concerning ...